Skip to content

Comparison of drugs Carbetocin and Oxytocin in normal delivery women

The efficacy of Intravenous Carbetocin versus Intravenous Oxytocin in active management of Third stage of labour in women delivering vaginally - A randomised controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067623
Enrollment
184
Registered
2024-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O721- Other immediate postpartum hemorrhage

Interventions

Intervention1: Group A: Intravenous Carbetocin which is a long-acting synthetic agonist analogue of human oxytocin.: Dose: 100 mcg
Route of administration: Intravenous with slow bolus method
Onset of action: 2 minutes
Duration of action: 2-4 hours after intravenous injection Control Intervention1: Group B: Intravenous Oxytocin which indirectly stimulates the contraction of uterine smooth muscle by increasing the so
Route of administration: slow Intravenous injection
Onset of action: 2-3 mins
Duration of action: 15-20 mins

Sponsors

NKP Salve Institute of Medical Sciences and Research Centre and Lata Mangeshkar Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women with a singleton-term pregnancy undergoing vaginal delivery.

Exclusion criteria

Exclusion criteria: 1. Hypertensive disorders in pregnancy 2. Moderate anemia (Hemoglobin less than 9gm per dl) 3. Placental abruption (determined by history and ultrasound report) 4. Placenta previa 5. Polyhydramnios 6. Grand Multipara 7. Known case of cardiac disease

Design outcomes

Primary

MeasureTime frame
1. Quantitative measure of blood loss during the third stage of labor. 2. Hemoglobin levelTimepoint: Immediately post delivery and on day 3 post delivery.

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDr Anuja Bhalerao

Department of Obstetrics and Gynaecology

anuja_bhalerao@yahoo.com9823680572

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026